Meet Mediget Teshome, M.D.
Mediget Teshome
Department of Breast Surgical Oncology, Division of Surgery
Present Title & Affiliation
Primary Appointment
Associate Professor, Department of Breast Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 2010 | Harvard School of Public Health, Boston, MA, USA, MPH, Masters of Public Health, Health Management and Policy |
| 2006 | University of Michigan Medical School, Ann Arbor, MI, USA, MD, Doctor of Medicine |
| 2001 | University of California Los Angeles, Los Angeles, CA, USA, BS, Physiological Sciences, Minor Public Policy |
Postgraduate Training
| 2016-2018 | Graduate Certificate, Health Care Management, Rice University Jesse H. Jones Graduate School of Business, Houston, TX |
| 2013-2014 | Fellowship, Breast Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX |
| 2008-2009 | Research Fellowship, Department of Surgery, Division of Vascular Surgery, Stanford University School of Medicine, Stanford, CA |
| 2006-2013 | Clinical Residency, General Surgery, Stanford Hospital and Clinics, Stanford, CA |
Board Certifications
| 2014 | American Board of Surgery |
Experience & Service
Academic Appointments
Assistant Professor, Department of Breast Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, 2015 - 2020
Assistant Professor, Department of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, 2014 - 2015
Administrative Appointments/Responsibilities
Division Professionalism Ambassador, The University of Texas MD Anderson Cancer Center, Houston, TX, 2022 - Present
Program Director, Department of Breast Surgical Oncology Fellowship Training Program, The University of Texas MD Anderson Cancer Center, Houston, TX, 2019 - Present
Fellowship Program Associate Director, Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2014 - 2019
Other Appointments/Responsibilities
Vice Chair, Publications Committee, American Society of Breast Surgeons, Houston, TX, 2021 - Present
Chair, Education Committee, Cancer Surgery Standards Program, American College of Surgeons, Houston, TX, 2020 - Present
Member, Komen Houston Medical Advisory Council, Houston, TX, 2019 - 2021
Institutional Committee Activities
Chair, Mid-Career Faculty Committee, 2021 - 2022
Member, Division of Surgery Diversity and Inclusion Committee, 2020 - Present
Vice Chair, Mid-Career Faculty Committee, 2020 - 2021
Associate Member, Institutional Review Board (IRB5), 2020 - 2022
Member, Faculty Senate Representative, Breast Surgical Oncology, 2019 - Present
Member, Faculty Academic Review Committee, 2019 - Present
Member, Handoff Communication Task Force, 2019 - 2020
Member, Diversity Council, 2018 - 2021
Member, Patient Experience Council, Nellie B. Connally Breast Center, 2018 - 2019
Member, Credentials Committee of the Medical Staff, 2018 - 2021
Co-Chair, Graduate Medical Education Diversity and Disparities Task Force, 2017 - 2019
Member, Graduate Medical Education Committee, 2017 - Present
Member, Junior Faculty Committee, 2017 - 2020
Member and Subject Matter Expert in Breast Surgery, One Connect for Breast Oncology, 2014 - 2016
Member, Program Evaluation Committee, Department of Surgical Oncology, 2014 - Present
Honors & Awards
| 2023 | Outstanding GME Program Director Award, Office of Graduate Medical Education, The University of Texas MD Anderson Cancer Center |
| 2023 | SUS Leadership scholarship, SSO and the Society of University Surgeons (SUS) |
| 2022 | Breast Surgical Faculty Excellence in Research Mentorship Award, University of Texas MD Anderson Cancer Center Breast Surgical Oncology Fellowship Program |
| 2018 | Top 1% National Performance Rating on CAHPS Patient Care Measures |
| 2017 | Fellow, American College of Surgeons |
| 2015 | Susan G Komen Breast Cancer Research Award, Society of Surgical Oncology |
| 2014 | The Corynne S. Uhl Award, Department of Surgical Oncology University of Texas MD Anderson Cancer Center |
| 2013 | Samuel L. Kountz Humanitarian Award, Stanford University Department of Surgery |
| 2013 | John Henry Smith Award, Stanford University Department of Surgery |
| 2009 | Carson Family Scholarship, Harvard School of Public Health |
| 2002 | Dean's Scholarship, University of Michigan Medical School |
Professional Memberships
Selected Publications
Peer-Reviewed Articles
- Zaveri S, Everidge S, FitzSullivan E, Hwang R, Smith BD, Lin H, Shen Y, Lucci A, Teshome M, Sun SX, Hunt KK, Kuerer HM. Extremely Low Incidence of Local-Regional Recurrences Observed Among T1-2 N1 (1 or 2 Positive SLNs) Breast Cancer Patients Receiving Upfront Mastectomy Without Completion Axillary Node Dissection. Ann Surg Oncol 30(12):7015-7025, 2023. e-Pub 2023. PMID: 37458948.
- Abuhadra N, Sun R, Bassett RL, Huo L, Chang JT, Teshome M, Clayborn AR, White JB, Ravenberg EE, Adrada BE, Candelaria RP, Yang W, Ding Q, Symmans WF, Arun B, Damodaran S, Koenig KB, Layman RM, Lim B, Litton JK, Thompson A, Ueno NT, Piwnica-Worms H, Hortobagyi GN, Valero V, Tripathy D, Rauch GM, Moulder S, Yam C. Targeting chemotherapy resistance in mesenchymal triple-negative breast cancer: a phase II trial of neoadjuvant angiogenic and mTOR inhibition with chemotherapy. Invest New Drugs. e-Pub 2023. PMID: 37043123.
- Whisenant MS, Alexander A, Woodward WA, Teshome M, Ueno NT, Williams LA. Inflammatory Breast Cancer: Understanding the Patient Experience. Cancer Nurs. e-Pub 2022. PMID: 36729801.
- Cobb AN, Diao K, Teshome M, Lucci A, Ueno NT, Stauder M, Layman RM, Kuerer HM, Woodward WA, Sun SX. Long-term Oncologic Outcomes in Patients with Inflammatory Breast Cancer with Supraclavicular Nodal Involvement. Ann Surg Oncol 29(10):6381-6392, 2022. e-Pub 2022. PMID: 35834145.
- Farley CR, Irwin S, Adesoye T, Sun SX, DeSnyder SM, Lucci A, Shaitelman SF, Chang EI, Ueno NT, Woodward WA, Teshome M. Lymphedema in Inflammatory Breast Cancer Patients Following Trimodal Treatment. Ann Surg Oncol 29(10):6370-6378, 2022. e-Pub 2022. PMID: 35854031.
- Adams AM, Vreeland TJ, Teshome M, Francescatti AB, Zheng L, Hunt KK, Katz MHG, Messick CA. American College of Surgeons Commission on Cancer Standard 5.7 for Total Mesorectal Excision for Mid-to-Low Rectal Cancer. J Am Coll Surg 234(6):1249-1253, 2022. e-Pub 2022. PMID: 35703824.
- Nissen AP, Vreeland TJ, Teshome M, Archer MA, Francescatti AB, Katz MHG, Hunt KK, Zheng L, Mullett TW. American College of Surgeons Commission on Cancer Standard for Curative Intent Pulmonary Resection. Ann Thorac Surg 113(1):5-8, 2022. e-Pub 2021. PMID: 34119494.
- Postlewait LM, Teshome M, Adesoye T, DeSnyder SM, Lim B, Kuerer HM, Bedrosian I, Sun SX, Woodward WA, Le-Petross HT, Valero V, Ueno NT, Lucci A. Contralateral Axillary Metastasis in Patients with Inflammatory Breast Cancer. Ann Surg Oncol 28(13):8610-8621, 2021. e-Pub 2021. PMID: 34125346.
- Kilgore LJ, Murphy BL, Postlewait LM, Liang DH, Bedrosian I, Lucci A, Kuerer HM, Hunt KK, Teshome M. Impact of the early COVID-19 pandemic on Breast Surgical Oncology fellow education. J Surg Oncol 124(7):989-994, 2021. e-Pub 2021. PMID: 34328640.
- Elmore LC, Kuerer HM, Barcenas CH, Smith BD, Miggins MV, Lucci A, Caudle AS, Meric-Bernstam F, Hunt KK, Teshome M. Clinical Course of Breast Cancer Patients with Local-Regional Progression During Neoadjuvant Systemic Therapy. Ann Surg Oncol 28(10):5477-5485, 2021. e-Pub 2021. PMID: 34247335.
- Adesoye T, Babayemi O, Postlewait LM, DeSnyder SM, Sun SX, Woodward WA, Ueno NT, Hunt KK, Lucci A, Teshome M. Inflammatory Breast Cancer at the Extremes of Age. Ann Surg Oncol 28(10):5626-5634, 2021. e-Pub 2021. PMID: 34292426.
- Partain N, Postlewait LM, Teshome M, Rosso K, Hall C, Song J, Meas S, DeSnyder SM, Lim B, Valero V, Woodward W, Ueno NT, Kuerer H, Lucci A. The Role of Mastectomy in De Novo Stage IV Inflammatory Breast Cancer. Ann Surg Oncol 28(8):4265-4274, 2021. e-Pub 2021. PMID: 33403525.
- Offodile AC, Asaad M, Boukovalas S, Bailey C, Lin YL, Teshome M, Greenup RA, Butler C. Financial Toxicity Following Surgical Treatment for Breast Cancer: A Cross-sectional Pilot Study. Ann Surg Oncol 28(5):2451-2462, 2021. e-Pub 2020. PMID: 33051742.
- Roy M, Teshome M, Damodaran S, Sahin AA, Khazai L, Arribas E, Candelaria RP, Scoggins ME, Lane DL, Giordano SH, Albarracin CT, Prieto VG, Nagarajan P. Male Mammary Paget Disease: A Tale of 2 Contrasting Cases. Am J Dermatopathol 42(12):981-985, 2020. PMID: 33289978.
- Alvarado MD, Mittendorf EA, Teshome M, Thompson AM, Bold RJ, Gittleman MA, Beitsch PD, Blair SL, Kivilaid K, Harmer QJ, Hunt KK. Correction to: SentimagIC: A Non-inferiority Trial Comparing Superparamagnetic Iron Oxide Versus Technetium-99m and Blue Dye in the Detection of Axillary Sentinel Nodes in Patients with Early-Stage Breast Cancer. Ann Surg Oncol 27(Suppl 3):979, 2020. PMID: 32514803.
- Singh P, Scoggins ME, Sahin AA, Hwang RF, Kuerer HM, Caudle AS, Mittendorf EA, Thompson AM, Bedrosian I, Teshome M, DeSnyder SM, Meric-Bernstam F, Hunt KK. Effectiveness and Safety of Magseed-localization for Excision of Breast Lesions: A Prospective, Phase IV Trial. Ann Surg Open 1(2), 2020. PMID: 34017965.
- Postlewait LM, Teshome M, DeSnyder SM, Lim B, Kuerer HM, Bedrosian I, Woodward WA, Ueno NT, Lucci A. Factors Associated with Pathological Node Negativity in Inflammatory Breast Cancer: Are There Patients Who May be Candidates for a De-Escalation of Axillary Surgery?. Ann Surg Oncol 27(12):4603-4612, 2020. e-Pub 2020. PMID: 32710271.
- Tzeng CD, Tran Cao HS, Roland CL, Teshome M, Bednarski BK, Ikoma N, Graham PH, Keung EZ, Scally CP, Katz MHG, Gershenwald JE, Lee JE, Vauthey JN. Surgical decision-making and prioritization for cancer patients at the onset of the COVID-19 pandemic: A multidisciplinary approach. Surg Oncol 34:182-185, 2020. e-Pub 2020. PMID: 32891326.
- Tzeng CD, Teshome M, Katz MHG, Weinberg JS, Lai SY, Antonoff MB, Bird JE, Shafer A, Davis JW, Adelman DM, Moon B, Reece G, Prabhu SS, DeSnyder SM, Skibber JM, Mehran R, Schmeler K, Roland CL, Tran Cao HS, Aloia TA, Caudle AS, Swisher SG, Vauthey JN. Cancer Surgery Scheduling During and After the COVID-19 First Wave: The MD Anderson Cancer Center Experience. Ann Surg 272(2):e106-e111, 2020. PMID: 32675511.
- Roland CL, Grubbs EG, Katz MHG, Teshome M, Hunt KK, Tzeng CW. Clinical trials - Designing, implementing, and collaborating. J Surg Oncol 122(1):25-28, 2020. e-Pub 2020. PMID: 32149390.
- Grant SR, Krishnamurthy S, Le-Petross C, Valero V, Teshome M, Woodward WA. An inflammatory imposter: Three cases of Mullerian carcinoma appearing as inflammatory breast cancer. Breast J 26(5):1022-1024, 2020. e-Pub 2020. PMID: 32891326.
- Smith BD, Lei X, Diao K, Xu Y, Shen Y, Smith GL, Giordano SH, DeSnyder SM, Hunt KK, Teshome M, Jagsi R, Shaitelman SF, Peterson SK, Swanick CW. Effect of Surgeon Factors on Long-Term Patient-Reported Outcomes After Breast-Conserving Therapy in Older Breast Cancer Survivors. Ann Surg Oncol 27(4):1013-1022, 2020. e-Pub 2020. PMID: 31916092.
- Stecklein SR, Rosso KJ, Nuanjing J, Tadros AB, Weiss A, DeSnyder SM, Kuerer HM, Teshome M, Buchholz TA, Stauder MC, Ueno NT, Lucci A, Woodward WA. Excellent Locoregional Control in Inflammatory Breast Cancer with a Personalized Radiotherapy Approach. Pract Radiat Oncol 9(6):402-409, 2019. e-Pub 2019. PMID: 31132433.
- Alvarado MD, Mittendorf EA, Teshome M, Thompson AM, Bold RJ, Gittleman MA, Beitsch PD, Blair SL, Kivilaid K, Harmer QJ, Hunt KK. SentimagIC: A Non-inferiority Trial Comparing Superparamagnetic Iron Oxide Versus Technetium-99m and Blue Dye in the Detection of Axillary Sentinel Nodes in Patients with Early-Stage Breast Cancer. Ann Surg Oncol 26(11):3510-3516, 2019. e-Pub 2019. PMID: 31297674.
- Sun S, van la Parra RFD, Rauch GM, Checka C, Tadros AB, Lucci A, Teshome M, Black D, Hwang RF, Smith BD, Krishnamurthy S, Valero V, Yang WT, Kuerer HM. Patient Selection for Clinical Trials Eliminating Surgery for HER2-Positive Breast Cancer Treated with Neoadjuvant Systemic Therapy. Ann Surg Oncol 26(10):3071-3079, 2019. e-Pub 2019. PMID: 31342361.
- Tevis SE, Bassett R, Bedrosian I, Barcenas CH, Black DM, Caudle AS, DeSnyder SM, Fitzsullivan E, Hunt KK, Kuerer HM, Lucci A, Meric-Bernstam F, Mittendorf EA, Park K, Teshome M, Thompson AM, Hwang RF. OncotypeDX Recurrence Score Does Not Predict Nodal Burden in Clinically Node Negative Breast Cancer Patients. Ann Surg Oncol 26(3):815-820, 2019. e-Pub 2018. PMID: 30556120.
- Kuerer HM, Rauch GM, Krishnamurthy S, Adrada BE, Caudle AS, DeSnyder SM, Black DM, Santiago L, Hobbs BP, Lucci A, Gilcrease M, Hwang RF, Candelaria RP, Chavez-MacGregor M, Smith BD, Arribas E, Moseley T, Teshome M, Miggins MV, Valero V, Hunt KK, Yang WT. A Clinical Feasibility Trial for Identification of Exceptional Responders in Whom Breast Cancer Surgery Can Be Eliminated Following Neoadjuvant Systemic Therapy. Ann Surg 267(5):946-951, 2018. e-Pub 2017. PMID: 28549010.
- Tadros AB, Yang WT, Krishnamurthy S, Rauch GM, Smith BD, Valero V, Black DM, Lucci A, Caudle AS, DeSnyder SM, Teshome M, Barcenas CH, Miggins M, Adrada BE, Hwang RF, Hunt KK, Kuerer HM. Identification of Patients With Documented Pathologic Complete Response in the Breast After Neoadjuvant Chemotherapy for Omission of Axillary Surgery. JAMA Surg 152(7):665-670, 2017. e-Pub 2017. PMID: 28423171.
- FitzSullivan E, Bassett RL, Kuerer HM, Mittendorf EA, Yi M, Hunt KK, Babiera GV, Caudle AS, Black DM, Bedrosian I, Reyna C, Teshome M, Meric-Bernstam F, Hwang R. Outcomes of Sentinel Lymph Node-Positive Breast Cancer Patients Treated with Mastectomy Without Axillary Therapy. Ann Surg Oncol 24(3):652-659, 2017. e-Pub 2016. PMID: 27822630.
- Vila J, Teshome M, Tucker SL, Woodward WA, Chavez-MacGregor M, Hunt KK, Mittendorf EA. Combining Clinical and Pathologic Staging Variables Has Prognostic Value in Predicting Local-regional Recurrence Following Neoadjuvant Chemotherapy for Breast Cancer. Ann Surg. e-Pub 2016. PMID: 27735826.
- Teshome M, Wei C, Hunt KK, Thompson A, Rodriguez K, Mittendorf EA. Use of a Magnetic Tracer for Sentinel Lymph Node Detection in Early-Stage Breast Cancer Patients: A Meta-analysis. Ann Surg Oncol 23(5):1508-14, 2016. e-Pub 2016. PMID: 26893221.
- Parent RJ, Plerhoples TA, Long EE, Zimmer DM, Teshome M, Mohr CJ, Ly DP, Hernandez-Boussard T, Curet MJ, Dutta S. Early, intermediate, and late effects of a surgical skills "boot camp" on an objective structured assessment of technical skills: a randomized controlled study. J Am Coll Surg 210(6):984-9, 2010. PMID: 20510808.
- Lee JT, Teshome M, de Virgilio C, Ishaque B, Qiu M, Dalman RL. A survey of demographics, motivations, and backgrounds among applicants to the integrated 0 + 5 vascular surgery residency. J Vasc Surg 51(2):496-502; discussion 502-3, 2010. PMID: 20022205.
- Lee JT, Qiu M, Teshome M, Raghavan SS, Tedesco MM, Dalman RL. The utility of endovascular simulation to improve technical performance and stimulate continued interest of preclinical medical students in vascular surgery. J Surg Educ 66(6):367-73, 2009. PMID: 20142137.
- Onyekwere OC, Campbell A, Teshome M, Onyeagoro S, Sylvan C, Akintilo A, Hutchinson S, Ensing G, Gaskin P, Kato G, Rana S, Kwagyan J, Gordeuk V, Williams J, Castro O. Pulmonary hypertension in children and adolescents with sickle cell disease. Pediatr Cardiol 29(2):309-12, 2008. e-Pub 2007. PMID: 17680298.
Invited Articles
- Fisher CS, Teshome M, Blair SL. 23rd Annual Meeting of the American Society of Breast Surgeons: Back to In-Person Scientific Exploration. Ann Surg Oncol 29(10):6087-6089, 2022. e-Pub 2022. PMID: 35902494.
- Adesoye T, Irwin S, Sun SX, Lucci A, Teshome M. Contemporary surgical management of inflammatory breast cancer: a narrative review. Chinese Clinical Oncology, 2021. PMID: 35016511.
- Teshome M. Role of Operative Management in Stage IV Breast Cancer. Surgical Clinics of North America 98(4):859-868, 2018. PMID: 30005779.
- Ueno NT, Espinosa Fernandez JR, Cristofanilli M, Overmoyer B, Rea D, Berdichevski F, El-Shinawi M, Bellon J, Le-Petross HT, Lucci A, Babiera G, DeSnyder SM, Teshome, M, Chang E, Lim B, Krishnamurthy S, Stauder MC, Parmer S, Mohamed MM, Alexander A, Valero V, Woodward WA. International consensus on the clinical management of Inflammatory Breast Cancer from the Morgan Welch Inflammatory Breast Cancer Research Program 10th Anniversary Conference. J Cancer 9(8):1437-1447, 2018. PMID: 29721054.
- Teshome M, Kuerer HM. Breast conserving surgery and locoregional control after neoadjuvant chemotherapy. European Journal of Surgical Oncology 43(5), 2017. e-Pub 2017. PMID: 28284519.
- Teshome M, Kuerer HM. Training of breast surgical oncologists. Chinese Clinical Oncology 5(3):43, 2016. e-Pub 2016. PMID: 27197510.
- Teshome M, Hunt KK. Sentinel Node Biopsy After Neoadjuvant Chemotherapy in Initial Node-Positive Patients: Why or Why Not?. Current Surgery Reports 3(5):doi:10.1007/s40137-015-0089-y, 2015. e-Pub 2015.
- Teshome M, Hunt KK. Neoadjuvant therapy in the treatment of breast cancer. Surgical Oncology Clinics of North America 23(3):505-523, 2014. e-Pub 2014. PMID: 24882348.
Manuals, Teaching Aids, Other Teaching Publications
- . ASBrS BESAP II - Cancer Management, 2017.
- Kuerer HM, Teshome M. MDACC Breast Surgical Oncology Handbook, 2015.
Editorials
- Cobb AN, Adesoye T, Teshome M. Progress and Persistent Challenges in Improving Care for Low-Income Women with Breast Cancer. Ann Surg Oncol. PMID: 35152360.
- Rojas KE, Teshome M, Tevis SE,. Unforeseen Collateral Damage of COVID-19 with the Virtualization of Fellowship Interviews. Annals of Surgery, 2021. PMID: 33914481.
- Teshome M, Chavez-MacGregor M. The Devastating Legacy of Breast Cancer Death in Sub-Saharan Africa-Maternal Orphans and a Cycle of Disadvantage. JAMA Oncol. PMID: 33355608.
Abstracts
- Basik M, Cecchini RS, De Los Santos JF, Umphrey HR, Julian TB, Mamounas EP, White J, Lucas PC, Balanoff C, Tan AR, Weber JJ, Edmonson DA, Brown-Glaberman UA, Diego EJ, Teshome M, Matsen CB, Seaward SA, Wapnir IL, Wagner JL, Tjoe JA, Thompson AM, Wolmark N. Primary analysis of NRG-BR005, a phase II trial assessing accuracy of tumor bed biopsies in predicting pathologic complete response (pCR) in patients with clinical/radiological complete response after neoadjuvant chemotherapy (NCT) to explore the feasibility of breast-conserving treatment without surgery (Abstract GS5-05). Cancer Research, Proceedings of the 2019 San Antonio Breast Cancer Symposium 80(4 Suppl):(Abstract GS5-05), 2020.
- Raber B, Bedrosian I, Kuerer HM, Holmes K, Sun S, Teshome M. National trends in access to inclusive LGBT patient centered oncology care. Society of Surgical Oncology 2019 Annual Meeting. e-Pub 2019.
- Singh P, Scoggins M, Sahin A, Hwang R, Kuerer H, Caudle AS, Mittendorf EA, Thompson AM, Bedrosian I, Teshome M, DeSnyder SM, Meric-Bernstam F, Hunt KK. Effectiveness and safety of massed-localization for surgical excision of breast lesions. Society of Surgical Oncology 2019 Annual Meeting. e-Pub 2019.
- Weiss A, Kuerer HM, Yang WT, Krishnamurthy S, DeSnyder SM, Black DM, Babiera GV, Teshome M, Hunt KK, Caudle AS. Potential for Targeted Axillary Dissection in Patients Who Do Not Receive Neoadjuvant Chemotherapy. American Society of Breast Surgeons 2017 Annual Meeting Official Proceedings:163, 2017.
- Kuerer HM, Rauch GM, Krishnamurthy S, Adrada BE, Caudle AS, DeSnyder SM, Santiago L, Lucci A, Hobbs BP, Gilcrease M, Hwang R, Candelaria RP, Chavez MacGregor M, Arribas E, Moseley T, Teshome M, Miggins MV, Smith BD, Valero V, Hunt KK, Yang WT. Feasibility trial for identification of patients for eliminating breast cancer surgery following neoadjuvant systemic therapy (Abstract P5-16-30). Cancer Research, Proceedings of the 2016 San Antonio Breast Cancer Symposium 77(4 Suppl), 2017.
- Teshome M, Tucker S,Hunt KK, Mitterndorf EM. Prognostic Value of Combined Clinical and Pathologic Staging Variables in Predicting Local-regional Recurrence following Neoadjuvant Chemotherapy for Breast Cancer, 2015.
- Teshome M, Ballman KV, McCall LM, Cormier JN, Giuliano A, Hunt KK. Long-term incidence of lymphedema after sentinel lymph node dissection for early stage breast cancer, 2014.
- Teshome M, Sun R, Ravenberg EE, Brewster A, Chavez-MacGregor M, White JB, Moulder S. Impact of race/ethnicity on triple negative breast cancer molecular features, treatment response and clinical outcomes in patients receiving neoadjuvant therapy. San Antonio Breast Cancer Symposium 2020.
Book Chapters
- Menen R,Teshome M. Invasive Breast Cancer. In: The MD Anderson Surgical Oncology Handbook, 2019.
- Teshome M,Kuerer HM. Neoadjuvant Therapy for Breast Cancer, Including Surgical Considerations. In: Breast Surgery: A Companion to Specialist Surgical Practice. Sixth Edition. 6th Edition, 2019.
- Simons MJ, Teshome M, Hunt KK. Inflammatory Breast Cancer. In: Complex General Surgical Oncology. Decker Medicine: Toronto, 2019.
- Teshome M, Kuerer HM. Career Development in Breast Surgical Oncology. In: Breast Surgical Techniques and Interdisciplinary Management. 2nd Edition. Springer: USA.
- Kilgore LJ, Miggins MV, Kuerer HM, Teshome, M. Integration of Neoadjuvant Systemic Therapy Into Surgical Practice. In: Breast Surgical Techniques and Interdisciplinary Management. 2nd Edition. Springer: USA.
- Teshome M, Kilgore LJ, Kuerer HM. Breast Cancer Training. In: American College of Surgeons: A Practical Guide to Managing Breast Cancer in Low-Middle Income Countries.
Grant & Contract Support
| Title: | The Human Breast Cell Atlas |
| Funding Source: | Silicon Valley Community Foundation (SVCF), also referred to as the Chan Zuckerberg Initiative (CZI) |
| Role: | Collaborator |
| Title: | Human Breast Cell Atlas Seed Network |
| Funding Source: | Silicon Valley Community Foundation (SVCF), also referred to as the Chan Zuckerberg Initiative (CZI) |
| Role: | Collaborator |